Grantham, Mayo, Van Otterloo & Co (GMO)
CME icon

Grantham, Mayo, Van Otterloo & Co (GMO)’s CME Group CME Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-2,263
Closed -$205K – 582
2015
Q4 		$205K Sell
2,263
-22,300
-91% -$2.1M ﹤0.01% 524
2015
Q3 		$2.28M Sell
24,563
-46,937
-66% -$4.46M 0.01% 317
2015
Q2 		$6.65M Sell
71,500
-15,400
-18% -$1.44M 0.02% 221
2015
Q1 		$8.23M Buy
86,900
+4,900
+6% +$454K 0.02% 211
2014
Q4 		$7.27M Sell
82,000
-12,600
-13% -$1.07M 0.02% 220
2014
Q3 		$7.56M Buy
94,600
+32,400
+52% +$2.44M 0.02% 228
2014
Q2 		$4.41M Sell
62,200
-5,910
-9% -$416K 0.01% 284
2014
Q1 		$5.04M Sell
68,110
-6,800
-9% -$513K 0.01% 299
2013
Q4 		$5.88M Buy
74,910
+1,100
+1% +$86.1K 0.01% 286
2013
Q3 		$5.45M Sell
73,810
-5,700
-7% -$420K 0.01% 296
2013
Q2 		$6.04M Buy
+79,510
New +$5.22M 0.02% 270

Other funds holding CME

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
TIM
Thornburg Investment Management Santa Fe, New Mexico $10.5B AUM 30.38% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s CME Position: Q1 2016 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of CME Group (CME) in Q1 2016, closing a stake of 2,263 shares — an estimated $205K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in CME in Q2 2013 and held it in 11 quarters. The position peaked at $8.23M in Q1 2015. 634 funds tracked by Wall St. Rank hold CME as of Q1 2016.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining CME Group position as of Q1 2016 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 2,263 CME Group shares in Q1 2016, an estimated $205K.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in CME Group in Q2 2013 and held it in 11 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s CME Group position peaked at $8.23M in Q1 2015.
  • 634 funds tracked by Wall St. Rank held CME Group as of Q1 2016.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2016, filed 13 May 2016.